World's largest medical technology company Medtronic Inc. (NYSE: MDT) has gained higher-than-expected fiscal fourth-quarter profit thanks to high sales of “recalled” defibrillator and the heart stent Endeavor.
The company announced that its net income reached $812 million, the same as a year earlier, or 72 cents a share. Adjusted profit of 78 cents a share was provided by a nickel.
Endeavor stent sales went up 56 percent, defibrillators and other heart rhythm devices climbed 5.4 percent.
The company also received benefit from sales of artificial spinal discs, Medtronic's second-biggest product, which jumped 35 percent to $869 million.
A U.S. publicly traded company faced in addition the highest increase of its shares in six months.
The shares increased $1.58, or 3.3 percent, to $49.46 at 11:40 a.m. in New York Stock Exchange composite trading.
The head of the Russian Finance Ministry, Anton Siluanov, said that the Americans would suffer additional losses if they impose sanctions on Russia's public debt